Korea Exchange will review whether to delist biotech company SillaJen Inc. due to the indictment of embezzlement and breach of trust charges against its officials.
Company executives were suspected of avoiding massive losses by selling large amounts of stocks ahead of its regulatory filing in August 2019, using inside information that its key product Pexa-Vec failed clinical tests.
Prosecutors also suspect that former Sillajen CEO Moon Eun-sang acquired a stake in the company without any capital by taking over bonds with warrants.
Moon resigned last week as Sillajen CEO after a warrant of arrest was issued against him by the Seoul Southern District Court for using undisclosed information to sell SillaJen stocks and committing other irregularities.
The resignation was also perceived as a means to help SillaJen avoid a delisting.
Top managers’ alleged embezzlement can be a basis for a company to lose eligibility for listing on the stock market.
KOSDAQ has suspended trading of SillaJen stocks since May 4.


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Instagram Outage Disrupts Thousands of U.S. Users
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



